Bayer AG NA (BAYN BE) stock market data APIs
€27.7691
0.35(1.3%)
as of July 18, 2025
Try our APIs with
free plan!
Bayer AG NA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BAYN.BE.
Prev. Close
27.7691
Open
28.1152
High
28.2663
Low
27.4386
52 wk Range
18.5656-30.8382
Market Cap
45 791 M
EPS
2.49
Dividends (Yield)
0.0495
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bayer AG NA data using free add-ons & libraries
Get Bayer AG NA Fundamental Data
Bayer AG NA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: 2.4
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bayer AG NA News
New
Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?
Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock has underperformed the medical sector and S&P 500 Index in this timeframe...
MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing Rights
Madrigal Pharmaceuticals MDGL shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark Office issued a Notice of Allowance for a new U.S. patent related to the FD...
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
Recursion Pharmaceuticals RXRX shares have gained 5.5% in a month. The stock gained momentum after the company announced the acquisition of Rallybio’s full stake in their joint venture earlier this ...
Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
Swiss pharma giant Novartis AG NVS reported better-than-expected results for the second quarter of 2025 and upped annual guidance for core operating income. Core earnings (excluding one-time charges)...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
